Skip to content

A Study on the Efficacy and Safety of Four Divine Spirits Jade Essence Paste in Promoting Spleen and Stomach Health

A Study on the Efficacy and Safety of Four Divine Spirits Jade Essence Paste in Promoting Spleen and Stomach Health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000829
Enrollment
Unknown
Registered
2026-03-31
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spleen deficiency

Interventions

Test group:Four Divine Spirits Jade Essence Paste, twice daily, 2 scoops (20g) per dose, taken continuously for 28 days.

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age 18–65 years (inclusive), no gender restrictions; (2) Diagnosed with spleen deficiency syndrome according to Traditional Chinese Medicine (TCM) pattern differentiation (meeting any of the following criteria qualifies for corresponding sub-pattern diagnosis: 2 primary and 2 secondary symptoms of spleen qi deficiency, spleen yin deficiency, or spleen yang deficiency plus tongue and pulse findings; or 1 primary symptom and 3 secondary symptoms plus tongue and pulse findings); (3) Hemoglobin (Hb) levels: males 80g/L = Hb 30 min), sleep maintenance disorder (=2 awakenings per night), early awakening, reduced sleep quality, and decreased total sleep time (typically <6.5 hours), accompanied by daytime dysfunction (primarily fatigue, depressed mood or irritability, physical discomfort, cognitive impairment, etc.); (5) Ability to complete the clinical study according to protocol requirements, with consent and signed informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals not meeting the diagnostic criteria for spleen deficiency syndrome or qi and blood deficiency syndrome; (2) Individuals with allergies to any component of the trial product; (3) Individuals who have used the following medications within the two weeks prior to the trial and cannot discontinue them (including iron-containing medications such as ferrous fumarate, ferrous citrate, etc.); Other chemical drugs with similar effects to the trial drug that directly impact evaluation metrics, such as vitamin B1, vitamin B2, etc.; Chinese patent medicines, such as Qi-Boosting and Blood-Nourishing Oral Liquid, Qi-Boosting and Blood-Nourishing Granules, etc.; Chinese herbs, such as Codonopsis, Ginseng, Pseudostellaria, Donkey-Hide Gelatin, Angelica, White Peony, Poria, etc.); (4) Individuals with cardiovascular, cerebrovascular, hepatic, renal, hematopoietic system disorders, irritable bowel syndrome, inflammatory bowel disease, or gastrointestinal neoplastic lesions; (5) Women in preconception, pregnancy, or lactation periods; individuals with allergic constitutions; (6) Patients with mental disorders (e.g., depression, anxiety) or cognitive impairment; (7) Individuals with alcohol abuse, smoking (=10 cigarettes daily), or severely irregular schedules (e.g., staying up past 11 PM =5 days/week); (8) Individuals who have taken medications (e.g., qi-tonifying and blood-nourishing agents, hypnotics, gastrointestinal motility drugs) or health supplements affecting qi and blood, sleep, or spleen-stomach function within the past month; (9) Individuals who have participated in other clinical trials within the past 3 months; (10) Individuals deemed unsuitable for the clinical trial by the investigator or unable to complete the study for other reasons.

Design outcomes

Primary

MeasureTime frame
Quantitative Grading Scoring Scale for Primary Symptoms of Spleen Deficiency Syndrome; Quantitative Grading Scoring Scale for Secondary Symptoms, Concomitant Symptoms and Physical Signs of Spleen Deficiency Syndrome; Quantitative Grading Scoring Scale for Tongue Manifestations of Subtypes of Spleen Deficiency Syndrome;

Secondary

MeasureTime frame
Qi Deficiency and Blood Deficiency Syndrome Questionnaire in Traditional Chinese Medicine;Anemia-related indicators: Hemoglobin, Red blood cell count, Hematocrit, Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), Mean corpuscular hemoglobin concentration (MCHC), Platelet count, Serum iron, Serum ferritin;Pittsburgh Sleep Quality Index;FS-14 Fatigue Scale;Fecal Consistency Score;

Countries

China

Contacts

Public ContactYangyang

The Second Affiliated Hospital of Anhui Medical University

iamyy1208333@163.com139 6503 2103

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026